Diakonhjemmet Hospital Pharmacy AS, Oslo, Norway.
Department of Pharmacy, University of Oslo, Oslo, Norway.
PLoS One. 2022 Sep 19;17(9):e0274907. doi: 10.1371/journal.pone.0274907. eCollection 2022.
The main objective of this study was to investigate whether systematic medication review conducted by clinical pharmacists can impact clinical outcomes and post-discharge outcomes for patients admitted to the emergency department.
This parallel group, non-blinded, randomized controlled trial was conducted in the emergency department, Diakonhjemmet Hospital, Oslo, Norway. The study was registered in ClinicalTrials.gov, Identifier: NCT03123640 in April 2017. From April 2017 to May 2018, patients ≥18 years were included and randomized (1:1) to intervention- or control group. The control group received standard care from emergency department physicians and nurses. In addition to standard care, the intervention group received systematic medication review including medication reconciliation conducted by pharmacists, during the emergency department stay. The primary outcome was proportion of patients with an unplanned contact with hospital within 12 months from inclusion stay discharge.
In total, 807 patients were included and randomized, 1:1, to intervention or control group. After excluding 8 patients dying during hospital stay and 10 patients lacking Norwegian personal identification number, the primary analysis comprised 789 patients: 394 intervention group patients and 395 control group patients. Regarding the primary outcome, there was no significant difference in proportion of patients with an unplanned contact with hospital within 12 months after inclusion stay discharge between groups (51.0% of intervention group patients vs. 53.2% of control group patients, p = 0.546).
As currently designed, emergency department pharmacist-led medication review did not significantly influence clinical- or post-discharge outcomes. This study did, however pinpoint important practical implementations, which can be used to design tailored pharmacist-led interventions and workflow regarding drug-related issues in the emergency department setting.
本研究的主要目的是调查临床药师进行的系统药物审查是否会影响急诊科住院患者的临床结局和出院后结局。
这是一项在挪威奥斯陆 Diakonhjemmet 医院急诊科进行的平行组、非盲、随机对照试验。该研究于 2017 年 4 月在 ClinicalTrials.gov 上注册,标识符为 NCT03123640。2017 年 4 月至 2018 年 5 月,纳入≥18 岁的患者并进行随机分组(1:1),分为干预组或对照组。对照组接受急诊科医生和护士的标准护理。除了标准护理外,干预组还接受了由药剂师进行的系统药物审查,包括药物重整,在急诊科住院期间进行。主要结局是出院后 12 个月内无计划与医院接触的患者比例。
共纳入并随机分为 1:1 的干预组或对照组 807 例患者。排除住院期间死亡的 8 例患者和缺乏挪威个人身份号码的 10 例患者后,主要分析包括 789 例患者:干预组 394 例患者和对照组 395 例患者。关于主要结局,出院后 12 个月内无计划与医院接触的患者比例在两组之间无显著差异(干预组 51.0%,对照组 53.2%,p=0.546)。
按目前设计,急诊科药剂师主导的药物审查并未显著影响临床或出院后结局。然而,这项研究确实指出了重要的实际实施措施,可以用于设计针对药物相关问题的定制药剂师主导的干预措施和工作流程,适用于急诊科环境。